ask="25.850"
ask_size="200"
average_daily_volume="543240"
bid="19.250"
bid_size="700"
book_value="3.500"
change="+0.175"
change_from_200_day_moving_average="2.047"
change_from_50_day_moving_average="0.233"
change_from_52_week_high="-2.625"
change_From_52_week_low="15.365"
change_in_percent="+0.708%"
close="24.875"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="1.575"
ebitda="46.75M"
eps_estimate_current_year="0.870"
eps_estimate_next_quarter="0.270"
eps_estimate_next_year="1.370"
ex_dividend_date="N/A"
float_shares="47709000"
high="24.900"
high_52_weeks="27.500"
last_trade_date="1/24/2017"
last_trade_price="24.875"
last_trade_size="36471"
last_trade_time="4:00pm"
low="23.700"
low_52_weeks="9.510"
market_capitalization="1.25B"
moving_average_200_day="22.828"
moving_average_50_day="24.642"
name="Supernus Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.000"
open="24.600"
pe_ratio="15.794"
peg_ratio="0.660"
percent_change_from_200_day_moving_average="+8.966%"
percent_change_from_50_day_moving_average="+0.944%"
percent_change_from_52_week_high="-9.545%"
percent_change_from_52_week_low="+161.564%"
previous_close="24.700"
price_eps_estimate_current_year="28.592"
price_eps_Estimate_next_year="18.157"
price_per_book="7.057"
price_per_sales="6.339"
revenue="195.29M"
shares_outstanding="50121000"
short_ratio="5.340"
stock_exchange="NGM"
symbol="SUPN"
volume="423252"
weeks_range_52="9.510 - 27.500"
